Multicenter, randomized, double-blind, placebo-controlled trial of deligoparin (ultra low molecular weight heparin) for active ulcerative colitis

2003 ◽  
Vol 124 (4) ◽  
pp. A67 ◽  
Author(s):  
Joshua Korzenik ◽  
Philip Miner ◽  
David Stanton ◽  
Kim Isaacs ◽  
Ellen Zimmerman ◽  
...  
2003 ◽  
Vol 124 (4) ◽  
pp. A68 ◽  
Author(s):  
Marc A. De Bievre ◽  
Anton A. Vrij ◽  
Ardi H. Oberndorff-Klein woolthuis ◽  
Henrik C. Hemker ◽  
Reinhold W. Stockbrugger

Blood ◽  
2015 ◽  
Vol 125 (14) ◽  
pp. 2200-2205 ◽  
Author(s):  
Elisabeth Pasquier ◽  
Luc de Saint Martin ◽  
Caroline Bohec ◽  
Céline Chauleur ◽  
Florence Bretelle ◽  
...  

Key Points The use of low-molecular-weight heparin did not improve live-birth rates in nonthrombophilic women with consecutive recurrent miscarriage. Prophylactic doses of low-molecular-weight heparin should no longer be prescribed in this clinical setting.


2007 ◽  
Vol 13 (6) ◽  
pp. 753-758 ◽  
Author(s):  
M. A. de Bièvre ◽  
A. A. Vrij ◽  
E. J. Schoon ◽  
G. Dijkstra ◽  
A. E. de Jong ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document